Amphastar Pharmaceuticals, Inc. — Director's Dealing 2018

Jun 12, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2018-06-07

Reporting Person: PRINS RICHARD K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-06-07	Common Stock	A	6590	—	Acquired	35434	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-06-07	Stock Option (right to buy)	$16.69	A	16679	Acquired	2026-06-07	Common Stock (16679)	Direct

Footnotes

F1: The reported shares are represented by restricted stock units, or RSUs, which vest in two equal annual installments beginning on June 7, 2019.

F2: Shares subject to the option vest in two equal annual installments beginning on June 7, 2019.